Prehospital tranexamic acid is associated with a survival benefit without an increase in complications: Results of two harmonized randomized clinical trials – PMC

A secondary analysis was performed using harmonized data from two large, double-blinded, randomized prehospital TXA trials. Prehospital TXA is safe and independently associated with a dose-dependent lower 28-day mortality risk and lower 24-hour red …
— Read on pmc.ncbi.nlm.nih.gov/articles/PMC11422517/